Phaeochromocytomas presenting as acute crises after beta blockade therapy

Clinical Endocrinology

Volumn 65, Issue 2, 2006, Pages 186-190

  Sibal, L ^a,c   Jovanovic, A ^a   Agarwal, S C ^b   Peaston, R T ^b   James, R A ^a   Lennard, T W J ^b   Bliss, R ^b   Batchelor, A ^b   Perros, P ^a  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b Newcastle upon Tyne Teaching Hospitals Foundation Trust   (United Kingdom)

^c FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; INOTROPIC AGENT; METOPROLOL;

ACUTE ABDOMEN; ADRENALECTOMY; ADULT; ALPHA ADRENERGIC RECEPTOR BLOCKING; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIOMYOPATHY; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; ELECTIVE SURGERY; FEMALE; HEART ARRHYTHMIA; HEMODYNAMICS; HUMAN; HYPERTENSION; INTENSIVE CARE; MALE; MYOCARDITIS; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURGICAL TECHNIQUE; VIRUS PNEUMONIA;

ACUTE DISEASE; ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADRENERGIC BETA-ANTAGONISTS; ADULT; CARDIOMYOPATHIES; CATECHOLAMINES; EMERGENCIES; FEMALE; HUMANS; MALE; METANEPHRINE; METOPROLOL; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; PHEOCHROMOCYTOMA; PNEUMONIA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33746102245     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02571.x     Document Type: Article

References (22)

1. Beard, C.M., Sheps, S.G., Kurland, L.T., Carney, J.A. & Lie, J.T. (1983) Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979. Mayo Clinic Proceedings, 58, 802-804.
2. Sutton, M.G., Sheps, S.G. & Lie, J.T. (1981) Prevalence of clinically unsuspected pheochromocytoma: review of a 50-year autopsy series. Mayo Clinic Proceedings, 56, 354-360.
3. Smythe, G.A., Edwards, G., Graham, P. & Lazarus, L. (1992) Biochemical diagnosis of pheochromocytoma by simultaneous measurement of urinary excretion of epinephrine and norepinephrine. Clinical Chemistry, 38, 486-492.
4. Bergland, B.E. (1989) Pheochromocytoma presenting as shock. American Journal of Emergency Medicine, 7, 44-48.
5. Shemin, D., Cohn, P.S. & Zipin, S.B. (1990) Pheochromocytoma presenting as rhabdomyolysis and acute myoglobinuric renal failure. Archives of Internal Medicine, 150, 2384-2385.
6. Werbel, S.S. & Ober, K.P. (1995) Pheochromocytoma: update on diagnosis, localization and management. Medical Clinics of North America, 79, 131-153.
7. Van Vleit, P.D., Burchell, H.B. & Titus, J.L. (1966) Focal myocarditis associated with pheochromocytoma. New England Journal of Medicine, 274, 1102-1108.
8. Peaston, R.T., Lennard, T.W.J. & Lai, L.C. (1996) Overnight excretion of urinary catecholamines and metanephrines in the detection of pheochromocytoma. Journal of Clinical Endocrinology and Metabolism, 81, 1378-1384.
9. Page, L.B., Raker, J.W. & Berberich, F.R. (1969) Pheochromocytoma with predominant epinephrine secretion. American Journal of Medicine, 47, 648-652.
10. Cheng, T.O. & Bashour, T.T. (1976) Striking electrocardiographic changes associated with pheochromocytoma. Chest, 70, 397-399.
11. Shimizu, K., Miura, Y., Meguro, Y., Noshiro, T., Ohzeki, T., Kusakari, T., Akama, H., Watanabe, T., Honma, H., Imai, Y., Yoshinaga, K. & Totsuka, H. (1992) QT prolongation with torsade de pointes in pheochromocytoma. American Heart Journal, 124, 235-238.
12. Schuiki, E.R., Jenni, R., Amann, F.W. & Zeigler, W.H. (1993) A reversible form of apical left ventricular hypertrophy associated with pheochromocytoma. Journal of the American Society of Echocardiography, 6, 327-331.
13. Imperato-McGinley, J., Gautier, T., Ehlers, K., Zullo, M.A., Goldstein, D.S. & Vaughan, E.D. Jr (1987) Reversibility of catecholamine-incluced dilated cardiomyopathy in a child with a pheochromocytoma. New England Journal of Medicine, 316, 793-797.
14. Hicks, R.J., Wood, B., Kalff, V., Anderson, S.T. & Kelly, M.J. (1991) Normalization of left ventricular ejection fraction following resection of pheochromocytoma in a patient with dilated cardiomyopathy. Clinical Nuclear Medicine, 16, 413-416.
15. Wilkenfeld, C., Cohen, M., Lansman, S.L., Courtney, M., Dische, M.R., Pertsemlidis, D. & Krakoff, L.R. (1992) Heart transplantation for end-stage cardiomyopathy caused by an occult pheochromocytoma. Journal of Heart and Lung Transplantation, 11, 363-366.
16. Cohen, C.D. & Dent, D.M. (1984) Pheochromocytoma and acute cardiovascular death (with special reference to myocardial infarction). Postgraduate Medical Journal, 60, 111-115.
17. De Leeuw, P.W., Waltman, F.L. & Birkenhager, W.H. (1986) Noncardiogenic pulmonary oedema as the sole manifestation of pheochromocytoma. Hypertension, 8, 810-812.
18. Bouloux, P.M.G. (2002) Pheochromocytoma, paragangliomas, and neuroblastoma. In: J.A.H. Wass, S.M. Shalet eds. Oxford Textbook of Endocrinology and Diabetes, Oxford University Press, New York, 775-789.
19. Bravo, E.L. & Tagle, R. (2003) Pheochromocytoma: state-of-the-art and future prospects. Endocrine Reviews, 24, 539-553.
20. Wark, J.D. & Larkins, R.G. (1978) Pulmonary oedema after propranolol therapy in two cases of pheochromocytoma. British Medical Journal, 1, 1395-1396.
21. Sloand, E.M. & Thompson, B.T. (1984) Propranolol induced pulmonary oedema and shock in a patient with pheochromocytoma. Archives of Internal Medicine, 144, 173-174.
22. Sawka, A.M., Jaeschke, R., Singh, R.J. & Young, W.F. Jr (2003) A comparison of biochemical tests for pheochromocytoma: measurement of fractionated plasma metanephrines compared with the combination of 24-hour urinary metanephrines and catecholamines. Journal of Clinical Endocrinology and Metabolism, 88, 553-558.